※ 기관로그인 시 무료 이용이 가능합니다.
※ 학술발표대회집, 워크숍 자료집 중 4페이지 이내 논문은 '요약'만 제공되는 경우가 있으니, 구매 전에 간행물명, 페이지 수 확인 부탁 드립니다.
4,000원
원문정보
초록
영어
This study was carried out to compare the bioavailability of SR TAB (test drug, cefaclor 375 mg/Tablet) with that of Ceclor SR IAB (reference drug) and to estimate the pharmacokinetic parameters of cefaclor in healthy Korean volunteers. The bioavailability was examined on 24 healthy volunteers who received a single dose (375 mg) of each drug in the fasting state in a randomized balanced 2-way crossover design. After dosing, blood samples were collected for a period of 7 hours. Plasma concentrations of cefaclor were determined using HPLC with UV detection. The pharmacokinetic parameters were calculated with non-compartmental pharmacokinetic analysis. The ANOVA test was utilized for the statistical analysis of the , log-transformed , log-transformed , and . The ratios of geometric means of between test drug End reference drug were , respectively. The of test drug and reference drug was confidence intervals of mean difference of logarithmic transformed were log0.90-log1.04 and log0.91-log1.13, respectively. It shows that the bioavailability of test drug is equivalent with that of reference drug.